Annual EBITDA
-$83.98 M
-$53.35 M-174.15%
31 December 2023
Summary:
Apogee Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$83.98 million, with the most recent change of -$53.35 million (-174.15%) on 31 December 2023. APGE annual EBITDA is now -174.15% below its all-time high of -$30.64 million, reached on 31 December 2022.APGE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$58.64 M
-$14.55 M-33.01%
30 September 2024
Summary:
Apogee Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$58.64 million, with the most recent change of -$14.55 million (-33.01%) on 30 September 2024. Over the past year, it has dropped by -$34.33 million (-141.26%). APGE quarterly EBITDA is now -3128.96% below its all-time high of -$1.82 million, reached on 01 June 2022.APGE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$169.01 M
-$34.33 M-25.49%
30 September 2024
Summary:
Apogee Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$169.01 million, with the most recent change of -$34.33 million (-25.49%) on 30 September 2024. Over the past year, it has dropped by -$99.16 million (-141.95%). APGE TTM EBITDA is now -9206.88% below its all-time high of -$1.82 million, reached on 01 June 2022.APGE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APGE EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -174.2% | -141.3% | -141.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APGE EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
| 5 y | 5 years | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
| alltime | all time | -174.2% | at low | -3129.0% | at low | -9206.9% | at low |
Apogee Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$58.64 M(+33.0%) | -$169.01 M(+25.5%) |
| June 2024 | - | -$44.09 M(+15.6%) | -$134.68 M(+23.0%) |
| Mar 2024 | - | -$38.15 M(+35.6%) | -$109.48 M(+30.4%) |
| Dec 2023 | -$83.98 M | -$28.14 M(+15.8%) | -$83.98 M(+20.2%) |
| Sept 2023 | - | -$24.30 M(+28.7%) | -$69.86 M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$18.89 M(+49.2%) | -$56.06 M(+43.8%) |
| Mar 2023 | - | -$12.66 M(-9.6%) | -$38.99 M(+48.1%) |
| Dec 2022 | -$30.64 M | -$14.01 M(+33.3%) | -$26.33 M(+113.7%) |
| Sept 2022 | - | -$10.51 M(+478.6%) | -$12.32 M(+578.6%) |
| June 2022 | - | -$1.82 M | -$1.82 M |
FAQ
- What is Apogee Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics annual EBITDA year-on-year change?
- What is Apogee Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly EBITDA year-on-year change?
- What is Apogee Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Apogee Therapeutics?
- What is Apogee Therapeutics TTM EBITDA year-on-year change?
What is Apogee Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of APGE is -$83.98 M
What is the all time high annual EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$30.64 M
What is Apogee Therapeutics annual EBITDA year-on-year change?
Over the past year, APGE annual earnings before interest, taxes, depreciation & amortization has changed by -$53.35 M (-174.15%)
What is Apogee Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of APGE is -$58.64 M
What is the all time high quarterly EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.82 M
What is Apogee Therapeutics quarterly EBITDA year-on-year change?
Over the past year, APGE quarterly earnings before interest, taxes, depreciation & amortization has changed by -$34.33 M (-141.26%)
What is Apogee Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of APGE is -$169.01 M
What is the all time high TTM EBITDA for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.82 M
What is Apogee Therapeutics TTM EBITDA year-on-year change?
Over the past year, APGE TTM earnings before interest, taxes, depreciation & amortization has changed by -$99.16 M (-141.95%)